Overview of Dr. Slotkin
Dr. Emily Slotkin is a pediatric hematologist/oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from University at Buffalo School of Medicine and has been in practice 12 years. She is one of 95 doctors at Memorial Sloan Kettering Cancer Center who specialize in Pediatric Hematology & Oncology. She has more than 30 publications and over 500 citings.
Office
1275 York Avenue
New York, NY 10065
Education & Training
- Jacobi Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 2008 - 2011
- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2008
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology
Certifications & Licensure
- FL State Medical License 2021 - Present
- NY State Medical License 2011 - 2026
- NJ State Medical License 2024 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Expanded Access Use of L-MTP-PE for the Treatment of Osteosarcoma
- Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor Start of enrollment: 2020 Dec 22
- A Study of LY2880070 and Gemcitabine in People With Ewing Sarcoma,Ewing-Like Sarcoma, and Desmoplastic Small Round Cell Tumor Start of enrollment: 2022 Mar 02
Roles: Contact, Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- 669 citationsExtracellular Vesicle and Particle Biomarkers Define Multiple Human CancersAyuko Hoshino, Han Sang Kim, Linda Bojmar, Kofi Ennu Gyan, Michele Cioffi
Cell. 2020-08-20 - 77 citationsClinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets.Benjamin A Nacev, Francisco Sanchez-Vega, Shaleigh A Smith, Cristina R Antonescu, Evan Rosenbaum
Nature Communications. 2022-06-15 - 26 citationsRelapsed and Refractory Pediatric Acute Myeloid Leukemia: Current and Emerging TreatmentsJennifer G. Davila, Emily K. Slotkin, Thomas M. Renaud
Paediatric Drugs. 2014-04-01
Press Mentions
- Drug Combination Shows Promise for Rhabdomyosarcoma, but Can It Get to Clinical Trials?December 9th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: